Attached files
| file | filename |
|---|---|
| 8-K/A - AMENDMENT TO CURRENT REPORT - FIRST CHINA PHARMACEUTICAL GROUP, INC. | v303301_8ka.htm |
 |
PARKER RANDALL CF (H.K.) CPA LIMITED |
February 18, 2012
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Re: First China Pharmaceutical Group, Inc.
Dear Sirs/Madams:
We have read Item 4.01 of the current report on Form 8-K dated January 16, 2012 of First China Pharmaceutical Group, Inc. (the “Registrant”) and we agree with the statements made therein concerning our firm.
Very truly yours,
/s/ Parker Randall CF
Parker Randall CF (H.K.) CPA Limited